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Co-culture of periodontal ligament ﬁbroblasts (PDLs) and SCC-25 oral squamous carcinoma cells
(OSCC) results in conversion of PDLs into carcinoma-associated ﬁbroblasts (CAFs) and induces
epithelial-to mesenchymal transition (EMT) of OSCC tumor cells. We hypothesized that
Curcumin targets this dynamic mutual interaction between CAFs and tumor cells. Normal and
2 mM Curcumin-treated co-culture were performed for 4 days, followed by analysis of tumor cell
invasivity, mRNA/protein expression of EMT-markers and mediators, activity measure of matrix
metalloproteinase 9 (MMP-9), and western blot analysis of signal transduction in tumor cells
and ﬁbroblasts. In Curcumin-treated co-culture, in tumor cells, the levels of nuclear factor kB
(NFkBa) and early response kinase (ERK)—decreased, in ﬁbroblasts, integrin av protein
synthesis decreased compared to corresponding cells in normal co-culture. The signal mod-
ulatory changes induced by Curcumin caused decreased release of EMT-mediators in CAFs and
reversal of EMT in tumor cells, which was associated with decreased invasion. These data
conﬁrm the palliative potential of Curcumin in clinical application.
& 2012 Elsevier Inc.Open access under CC BY-NC-ND license.Introduction
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which leads to gain of mesenchymal characteristics in epithelial
cells. This enables them to migrate across the basal membrane
and initiate metastasis formation [2–4]. This phenotype of tumor
cells is a consequence of a communication between tumor cells
and carcinoma associated ﬁbroblasts (CAFs), which is orche-
strated by cytokine–chemokine interactions [2,3,5].
In a co-culture model of periodontal ligament ﬁbroblasts
(PDLs) and SCC-25 oral squamous carcinoma cells (OSCC), we
investigated the conversion of normal ﬁbroblasts into CAFs and
EMT in SCC-25 cells [2]. We observed that SCC-25 cells produce
active, processed IL-1b, and PDLs possess receptor for it, whose
expression is increased in the presence of SCC-25 tumor cells.
Upon interaction with SCC-25 cells active IL-1b signaling occurs
in co-cultured ﬁbroblasts leading to induction of several genes
involved in tumor progression, including interleukin-6 (IL-6) and
prostaglandin-endoperoxide synthase 2 (COX-2) [3]. In fact,
dynamic interaction between CAFs and tumor cells dictate gene
expression changes in the interacting cells, which covers major
events of tumor progression. We have previously reported that
ﬁbroblasts might facilitate the invasion of SCC-25 cells by
expressing matrix metalloproteinases (MMPs) on their own, in
response to tumor-cell-produced cytokines (i. e. IL-1b), to TGF-
b)1 or to integrin–ﬁbronectin interactions [5]. At the same time,
the tumor cells are capable of activating pro-MMPs [5]. For
instance pro-MMP-2 is higher expressed in ﬁbroblasts, but its
activation only occurred in the presence of tumor cells. In
contrast to pro-MMP-2, pro-MMP-9 is produced by SCC-25 cells,
not by PDLs, and pro-MMP-9 is activated on the surface of tumor
cells. In fact, the paracrine interaction between CAFs and tumor
cells is required for the upregulation of MMP-9 [5]. A dynamic
mutual interaction of CAFs and tumor cells is a prerequisite for
tumor progression and it represents a signiﬁcant therapeutic
target.
Curcumin (diferuloylmethane) is a polyphenol derived from
the Curcuma longa plant, commonly known as turmeric. Curcu-
min has been used extensively in Ayurvedic medicine for
centuries, as it is nontoxic and has a variety of therapeutic
properties including anti-oxidant, analgesic, anti-inﬂammatory
and antiseptic activity. Curcumin has been found to possess anti-
cancer activities via its effect on a variety of biological pathways
involved in mutagenesis, oncogene expression, cell cycle regula-
tion, apoptosis, tumorigenesis and metastasis. Curcumin has
shown anti-proliferative effect in multiple cancers, and is an
inhibitor of the transcription factor NFkBa and downstream gene
products (including c-Myc, Bcl-2, COX-2, nitric oxide synthase
(NOS), Cyclin D1, tumor necrosis factor alpha (TNF-a), interleu-
kins and MMP-9) [6]. Studies of Curcumin in various head and
neck cancer cell lines have demonstrated decreased
cell growth and survival, which was related with inhibition of
NFkBa activation [7].
The lipophilic nature of Curcumin and relative insolubility in
aqueous solutions, combined with short half life and low bioa-
vailability following oral administration has presented a signiﬁ-
cant challenge in developing an effective delivery system for its
use as a chemotherapeutic agent [8]. In an effort to overcome
this obstacle, various strategies are being tried including the
development of liposomal, phospholipid and nanoparticulated
formulations of the compound to enable intravenous adminis-
tration [8]. In a pharmacokinetic study performed in rats,following oral administration of the Curcumin–phosphatidyl
choline complex, the maximal achieved plasma concentration
of Curcumin was around 800 ng/ml [9], which is 2.17 mmol/L. In a
human phase 1 trial Curcumin was orally applied for advanced
colorectal cancer, patients consumed 3.6 g of Curcumin daily, and
up to 2–2.5 mM Curcumin concentrations have been detected in
their urine. Temporary stable diseases have been observed in two
patients, whereas no response was observed in the other study
participants [10]. In an in vitro study: Curcumin above 50 mmol/L
concentration caused growth suppression of HNSCC cell lines
[11], which is much higher than the concentrations achievable
in vivo.
In the current study we hypothesize that Curcumin targets the
dynamic mutual interaction of CAFs and tumor cells in head and
neck cancer. We assume that Curcumin achieves this effect even
at those low concentration levels that are detected in blood or
urine (2 mmol/L) in previous in vivo studies. We presume that it
modiﬁes the interaction between carcinoma associated ﬁbro-
blasts and tumor cells, which leads to decrease of the tumor cell
invasivity, without growth suppression effects on tumor cells.Materials and methods
Chemicals
Curcumin powder was purchased from Sigma-Aldrich (Vienna,
Austria). Curcumin is a lipophilic polyphenol and thus is inso-
luble in water, but is readily soluble in organic solvents such as
dimethyl sulfoxide (DMSO), acetone and ethanol [12,13]. A stock
solution of Curcumin was prepared at 100 mmol/L in DMSO.
Chemicals used in the study were purchased from Sigma, from
Roth (Karlsruhe, Germany) and from Serva (Heidelberg,
Germany).
Cell lines
PDL ﬁbroblasts [2,14] were isolated from periodontal ligament
(PDL) and received from Prof. Dr. Miosge (Department of
Prosthodontics, Georg-August-University, Go¨ttingen, Germany)
[14]. They were routinely cultured in DMEM-low glucose (PAA,
Pasching, Austria) supplemented with 10% fetal bovine serum
(FBS) (PAA), 2 mM L-glutamine, 100 units/ml penicillin, 100 mg/
ml streptomycin. SCC-25 cells were purchased from the German
Collection of Microorganisms and Cell Cultures (DSMZ, Braunsch-
weig, Germany, ref. ACC 617), and were routinely cultured in
DMEM/F12 (PAA) supplemented with 10% FBS (PAA), 2 mM
L-glutamine, 1 mM sodium pyruvate, 100 units/ml penicillin,
100 mg/ml streptomycin [2,3,5,15]. BEAS-2B immortalized bron-
chial epithelial cells [15,16] were purchased from the European
Collection Agency of Cell Cultures (Salisbury, UK), were routinely
cultured in RPMI-1640 (PAA) supplemented with 10% fetal
bovine serum (FBS) (PAA), 2 mM L-glutamine, 100 units/ml
penicillin, 100 mg/ml streptomycin.
Treatment of cells with Curcumin
The Curcumin treatment of the cells is based on a published Ref.
[11]. SCC-25 cells, PDL ﬁbroblasts and BEAS-2B immortalized
epithelial cells were plated in 96-well plates, with 104 cells per
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sion/dish, and were allowed to grow for 24 h. The cells were then
serum starved (using 0.3% fetal bovine serum containing med-
ium) [11]. Curcumin was diluted to ﬁnal concentrations ranging
from 2 to 250 mmol/L. To control experiments 2.5 ml DMSO/ml
medium was added, representing the highest DMSO content of
the treated cells. After 24 h serum starvation treatment was
started with several Curcumin concentrations in 10% serum-
containing medium for 24 h. After completion of the treatment,
cell viability was measured using the 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide assay (MTT) system [17],
and cell counts were determined.
Co-culture treatment with Curcumin
PDL ﬁbroblasts were plated in DMEM-low-glucose/10% FBS at
104 cells/ml on cell culture inserts containing a 0.45 mm plastic
membrane ﬁlter, and SCC-25 cells were cultured separately in
DMEM-F12/10% FBS at 4104 cells/ml in wells of six-well plate
(Greiner, Kremsmu¨nster, Austria) [2,3,5]. Each experimental
system contained controls, which were plated in the same way.
After 48 h the cell culture inserts with the ﬁbroblasts were put
together with the wells containing SCC-25 cells, the medium was
replaced in the inserts and in the wells of six-well plates by
DMEM-low-glucose–DMEM-F12/5% FBS. The controls were not
co-cultured, but received the same mixed medium. In the
controls the ﬁbroblasts or SCC-25 cells were omitted [2,3,5].
Direct contact of the cells was prevented by a 0.45 mm plastic
membrane, but there was a continuous communication of
soluble substances between the upper and the lower cells. Some
of the co-cultures were treated with 2 mM Curcumin for 3 days,
by daily medium and Curcumin replacements. Similarly, the
medium in the co-cultures and in the controls was changed
daily. After 3 days of co-culture and treatments, on the fourth
day, the control cells and the cells in co-culture received mixed
DMEM-low-glucose–DMEM-F12/0.3% FBS, the treated co-
cultures were additionally provided with 2 mM Curcumin for
the last 24 h. On the ﬁfth day, after co-culture and treatments,
the experiment was terminated; the supernatants were used for
ELISA and gelatinase assays, the cells in the inserts and in the
wells were used for RNA isolation, or for protein fractionation.
This experimental setup was performed in four repeats.
Tumor cell migration and invasion assays
Co-culture and Curcumin treatment of co-culture have been
performed as described above, for migration and invasion assays
SCC-25 cells were used further. After completion of co-culture
with and without Curcumin treatment, control, co-cultured and
co-cultured/Curcumin-treated SCC-25 cells were released by
trypsinization, and the cells were counted. From all SCC-25 cell
samples (control, co-cultured and co-cultured, Curcumin-trea-
ted), 2 ml, 2105 cells/ml suspensions were prepared in DMEM/
F12–0.3% serum. For cell migration assays 2 ml DMEM/F12–10%
fetal bovine serum (FBS) medium was added in 6-well plates
under 8 mm inserts. 1 ml cell suspension (in DMEM/F12–0.3%
serum) was added into the inserts [18]. For cell invasion assays
Matrigel (Sigma) was diluted to 200 mg/ml and applied to the top
side of the ﬁlter for coating for 1 h [18]. 1 ml cell suspension (in
DMEM/F12—0.3% serum) was added into the inserts and 2 mlDMEM/F12—10% fetal bovine serum (FBS) medium was added in
6-well plates under the inserts. After incubation for 24 h at 37 1C
for both the migration and the invasion experiments, the cells in
the upper surface of the 8 mm inserts were carefully removed
with a cotton swab, and migrated or invaded cells were
trypsinized and counted from the lower surface of the 8 mm
inserts [18].
RNA extraction, reverse transcription and real-time
RT-PCR
Total RNA was isolated and reverse transcribed from control and
co-cultured cells as described before, real-time RT-PCR was done
as referenced [2,19]. All used human PCR primers were published
previously: b-actin [20], E-cadherin, vimentin [21], stoma-derived
factor-1 (SDF-1) [22], brain-derived neurotrophic factor (BDNF) [2];
b-actin functioned as housekeeping gene [2], and did not show
signiﬁcant changes in co-culture and treated co-culture condi-
tions compared to controls. The relative gene expression was
calculated as previously reported [19].
Protein expression and activity measurements
Conditioned media were collected from both the ﬁbroblast and
the SCC-25 side of the co-culture, Curcumin-treated co-culture
and also from the control cells. From the supernatant (condi-
tioned media) of the control cells and from both sides of the
co-cultures 20 ml medium was used from all samples for gelati-
nase zymogram [5]. Supernatants were always examined at
low-serum-containing conditions [5]. Cells after co-culture,
Curcumin-treated co-culture and controls were used for non-
nuclear and nuclear protein fractionation, as described pre-
viously [3,23]. For gelatinase analysis supernatants and cytoplas-
matic/membrane fractions were subjected to polyacrylamide gel
electrophoresis using gelatin-containing 10% polyacrylamide gels
[5,24].
For the analysis of integrin av, phospho-another kinase of
transcription (p-Akt), (phospho)-neurothrophin receptor B (TrkB,
p-TrkB), (phospho)-interleukin-1 receptor-associated kinase-1
(IRAK, p-IRAK) and nuclear factor kappa B alpha (NFkBa) non-
nuclear protein fractions were subjected to western blot analysis
[2] as described previously [2,3,5,15,23]. Identical equal protein
containing 20 ml samples were loaded for western blot, which
was performed with the JLA20 b-actin antibody (in 1:100
dilution), purchased from Developmental Studies Hybridoma
Bank (Iowa City, Iowa, USA) as a loading control [25].
For the analysis of (phospho)-early response kinase (ERK1/2
and p-ERK1/2) and of NFkBa nuclear protein fractions were
subjected to western blot analysis [2,3,5,15,23]. Details of the
used antibodies are available in Supplementary Table 1.
ELISA
Conditioned media were collected from both the ﬁbroblast and
the SCC-25 side of the co-culture, Curcumin-treated co-culture
and also from the control cells, as described above. From the
supernatant (conditioned media) of the control cells and from
both sides of the co-culture 100 ml medium was used from all
samples for quantitative TGF-b1, SDF-1 and BDNF detection
using RayBio human ELISA kits (RayBiotech, Norcross, GA, USA).
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Each experiment was performed in four independent sets con-
taining four biological repeats/set. The relative gene-expression
results were tested for normal distribution by DAgostino and
Pearson omnibus normality test using the Graphpad Prism 4.03
(Graphpad Software Inc., San Diego, CA, USA). Signiﬁcance of
changes in co-culture vs. controls was tested by non-parametric
tests (Mann–Whitney) and Students t-tests depending on the
distribution of the data. The independent experimental sets were
then compared for reproducibility. Only reproducible changes
with a po0.05 level [2,3] were considered as signiﬁcant.Results
Determination of growth suppressing concentrations of
Curcumin in SCC-25, BEAS-2B cells and in PDL ﬁbroblasts
SCC-25 cells, BEAS-2B cells and PDL ﬁbroblasts were treated with
Curcumin as described previously [11]. Curcumin showed sig-
niﬁcant reduction of MTT-measured metabolic activity in SCC-25
cells (Fig. 1 and Table 1), if it was administered over 2 mM
concentration. In addition, at a concentration over 25 mM,
Curcumin also caused signiﬁcant reduction of MTT-measured
metabolic activity in BEAS-2B not transformed epithelial cells,
and at higher concentrations it reduced the metabolic activity of
PDL ﬁbroblasts (Fig. 1 and Table 1). Nevertheless, in tumor cells
the effect was clearly stronger. Selectivity of Curcumin has been
shown at concentrations up to 60 mM (Fig. 1), by more intensive
growth suppression of SCC-25 cells. The MTT results have beenFig. 1 – Relative metabolic activity measured by MTT-assay in Cu
Curcumin-treatment related to DMSO-treated control cells.
Table 1 – Metabolic activity measured by MTT-assay in Curcumi
treatment related to DMSO-treated controls. 2 lM Curcumin con
cells, in PDL ﬁbroblasts or BEAS-2B cells this concentration was in
used 2 lM Curcumin concentrations for further experimentatio
Control 2 lM Curcumin
SCC-25 1.0070.015 0.9570.007
BEAS-2B 1.0070.02 1.0070.02
PDL ﬁbroblasts 1.0070.01 1.0070.006also conﬁrmed by determination of the cell numbers after
Curcumin treatment (not shown). 2 mM Curcumin concentration
caused up to 5% loss of the metabolic capacity of SCC-25 cells, in
PDL ﬁbroblasts or BEAS-2B cells this concentration was ineffec-
tive. In this regard, at the level of at least 95% viability, we have
used 2 mM Curcumin for further experimentation. Interestingly,
this concentration level has been reached by previous in vivo
studies or in clinical trial in blood or in urine [9,10].Inﬂuence of Curcumin on the migration and invasion of
SCC-25 tumor cells in co-culture system with PDL
ﬁbroblasts
We have recently reported that several days co-culture of SCC-25
tumor cells with PDL ﬁbroblasts leads to EMT of tumor cells [2],
which might be associated with increased tumor cell invasivity.
Adopting a method described by Sun et al. [18] we have
investigated the migratory and invasive capacity of SCC-25 cells
after normal or Curcumin-treated co-culture. As previously
described, 2 mM Curcumin had no growth suppressive effects
either on SCC-25 cells or on PDLs. Migration and invasion tests
have been performed with SCC-25 cells immediately after
normal or Curcumin-treated co-culture. Since the cell number
of SCC-25 cells slightly increased after co-culture compared to
control cells (not shown), before performing migration and
invasion tests, the number of the cells was adjusted to 2105
cells/ml in all cases. As depicted in Fig. 2A and B: both the
migration and invasion capacities of SCC-25 cells increased after
co-culture, whereas in 2 mM Curcumin-treated co-culture both of
them remained at the control level.rcumin-treated SCC25, BEAS-2B and PDL ﬁbroblast cells after
n-treated SCC25, BEAS-2B and PDL cells after Curcumin-
centration caused 5% loss of the metabolic capacity of SCC-25
effective. In this regard, at the level of 95% viability, we have
n. The dose limiting cells were the carcinoma cells.
15.62 lM Curcumin 125 lM Curcumin
0.4670.005 0.3170.001
0.8570.01 0.5370.007
0.9570.01 0.6670.02
Fig. 2 – Effects of Curcumin on the invasivity and EMT of SCC-25 cells in co-culture. After 4 days of normal or Curcumin-treated
co-culture (PDL ﬁbroblasts with SCC-25 cells): migration (A) and invasivity (B) of SCC-25 cells was determined as described
in Materials and methods. Co-culture resulted in signiﬁcant increase of migration (A) and invasivity (B) of SCC-25 cells, which has
remained at the control level if the co-culture was treated with 2 lM Curcumin. MMP-9 gelatinase activity in non-cell-nuclear
fraction (C) and in conditioned medium of SCC-25 cells (D) in control (1), co-cultured (2 and 3), co-cultured and 2 lM Curcumin-
treated (4 and 5) conditions. FBS was used as positive control (6). Relative gene expression of vimentin (E) and E-cadherin
(F) in control, co-cultured and 2 lM Curcumin treated-co-cultured SCC-25 cells. Co-culture induced a signiﬁcant increase of
vimentin gene expression in SCC-25 cells (E), which has remained at the control level if the co-culture was treated with 2 lM
Curcumin. At the same time, co-culture with PDL cells induced a signiﬁcant decrease of E-cadherin gene expression in SCC-25
cells (F), which has remained at the control level if the co-culture was treated with 2 lM Curcumin.
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related to production and activation of matrix metalloproteinases.
We have previously reported the increased activity of MMP-9 in
co-cultured SCC-25 cells [5], which has been conﬁrmed in the
current study as well (Fig. 2C and D). Mostly pro-MMP-9 gelatinase
bands increased in non-cell-nuclear protein fractions (Fig. 2C),
whereas in the conditioned media (Fig. 2 D) the increase of pro-
MMP-9 was less evident, and active MMP-9 was not detectable.
Nevertheless, in 2 mM Curcumin-treated, co-cultured SCC-25 cells
the MMP-9 gelatinase activity in cell lysates and in conditioned
medium remained at the control level (Fig. 2C and D).Inﬂuence of Curcumin on EMT of SCC-25 tumor cells in
co-culture system with PDLs
In addition to the achieved invasive phenotype, the co-culture
with PDL ﬁbroblasts lead to induction of the mesenchymal
marker, vimentin gene in SCC-25 cells, as published before [2]
(Fig. 2E). This was accompanied by the down-regulation
of E-cadherin [2] (Fig. 2F). Interestingly, both vimentin
and E-cadherin gene expression have remained at the control
level if the co-culture was treated with 2 mM Curcumin (Fig. 2E
and F).
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tumor cells in co-culture system with PDL ﬁbroblasts
In order to investigate the signal transduction effects of Curcumin on
SCC-25–PDLs interactions, we have fractionated proteins of cyto-
plasma/cell membrane and nucleus [23] of both SCC-25 cells and
PDLs. We have previously published that integrin av (ITGA5)
expressed in SCC-25 cells might contribute to regulation of MMP-9
[5]. Conﬁrming our previous data, in the non-nuclear extracts,
ITGA5 was upregulated (up to 153% of the control by densitometry
of western blots normalized to beta-actin) in SCC-25 cells in
co-culture, whereas, in 2 mMCurcumin-treated co-culture, the ITGA5
protein levels were slightly reduced (to 9070.3% compared to
normal co-cultured SCC-25 cells by densitometry of western blots
normalized to beta-actin) (Fig. 3A, top panel). EMT and invasivity in
tumor cells of HNSCC might be mediated by the receptor of
brain-derived neurotrophic factor (BDNF): TrkB [2]. The active
phosphorylated form of TrkB was analyzed in the non-nuclear
extracts of SCC-25 cells by western blot in control, co-cultured and
Curcumin-treated co-cultured conditions. Its protein levels increased
in co-culture (to 171710% by densitometry of western blots
normalized to beta-actin) and returned to control levels in
Curcumin-treated co-cultured conditions (to 7577.5% of the normal
co-culture by densitometry of western blots normalized to beta-
actin) (Fig. 3A).
Two main signal targets of Curcumin [18] have also been
investigated at protein level in co-cultured and 2 mM Curcumin-
treated, co-cultured SCC-25 cells, one is Akt and the other is
NFkBa. The active phospho-Akt has suffered only minor changes,
9274% in Curcumin-treated, co-cultured compared to normal
co-cultured SCC-25 cells (Fig. 3A). In contrast, cytoplasmatic
levels of p65 NFkBa have dramatically decreased to 45710%
(by densitometry normalized to beta-actin) in SCC-25 cells ofFig. 3 – Effects of Curcumin on the signal transduction of SCC-25
with SCC-25 cells) and in some experiments treatment of the co-
(B) fractions of SCC-25 cells were analyzed by western blot using
integrin av (ITGA5), p-TrkB, p-Akt, NFjBa, in cell nuclear fraction
loaded on polyacrylamide gels: MW: molecular weight marker, co
Curcumin-treated (4 and 5) SCC-25 cells.Curcumin-treated co-culture compared to normal co-culture
(Fig. 3A). These changes in the cytoplasma levels of p65 NFkBa
have been accompanied by similar changes in the cell nuclear
fraction (Fig. 3B top panel). The relation of nuclear NFkBa
density to cytoplasmatic density in control, co-cultured and
Curcumin-treated co-cultured SCC-25 cells was as follows:
0.92, 0.87, and 1.39. In addition, in cell nuclear extracts the
protein levels of (phospho)–ERK1/2 have decreased to 7373%
(by densitometry normalized to beta-actin) in Curcumin-treated,
co-cultured compared to normal co-cultured SCC-25 cells (Fig. 3
B middle and lowest panel). The relation of pERK to ERK density
was the same in control, co-cultured and Curcumin-treated
co-cultured SCC-25 cells: 1.0570.04.
Inﬂuence of Curcumin on expression of EMT-mediators in
ﬁbroblasts in co-culture system with SCC-25 cells
As we have previously reported, in co-culture between SCC-25
cells and PDLs, ﬁbroblasts were converted to CAFs, which in
return initiated EMT of SCC-25 cells. EMT has been induced in
tumor cells due to the release of EMT-mediators in CAFs, such as
stroma derived factor (SDF) or brain derived neurotrophic factor
(BDNF) [2]. As previously described, in 2 mM Curcumin treated
co-culture, vimentin and E-cadherin gene expression levels
remained at the control level in SCC-25 cells, which was
accompanied with reduced migratory and invasive activity. In
this regard, it seems that treatment of SCC-25–PDLs co-culture
with Curcumin abrogates EMT in tumor cells. In a further step, it
was investigated, if it might be due to the reduced production
levels of EMT-mediators in co-cultured ﬁbroblasts.
After 4 days of co-culture and in some experiments Curcumin-
treated co-culture, relative gene expression (Fig. 4A and B) and
protein synthesis (Fig. 4C and D) of SDF-1a (Fig. 4A and C) andcells in co-culture. After 4 days of co-culture (PDL ﬁbroblasts
culture with 2 lM Curcumin non-nuclear (A) and cell nuclear
b-actin as loading control. In non-nuclear protein fraction:
: NFjBa, ERK1/2 and p-ERK1/2 have been analyzed. Samples
ntrol (1), co-cultured (2 and 3), co-cultured and 2 lM
Fig. 4 – Effects of Curcumin on gene expression and production of EMT-mediators in PDL ﬁbroblasts in co-culture. After 4 days of
co-culture (PDL ﬁbroblasts with SCC-25 cells) and in some experiments treatment of co-culture with 2 lM Curcumin, relative
gene expression (A and B) and protein synthesis (measured by ELISA, shown as absorption at 450 nm) (C and D) of SDF-1a (A and
C) and BDNF (B and D) have been analyzed in control, co-cultured and 2 lM Curcumin treated-co-cultured ﬁbroblasts. Co-culture
induced a signiﬁcant increase of SDF-1a and BDNF gene expression and protein synthesis in ﬁbroblasts, both of which has
remained at the control level if the co-culture was treated with Curcumin.
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and 2 mM Curcumin treated-co-cultured PDLs. Co-culture
induced a signiﬁcant increase of SDF-1a and BDNF gene expres-
sion and protein synthesis in PDLs (Fig. 4), both of which has
remained at the control level if the co-culture was treated with
Curcumin.
Inﬂuence of Curcumin on signal transduction of PDLs in
co-culture system with SCC-25 cells
Similarly to the SCC-25 cells, also in PDL ﬁbroblasts, signal
transduction effects of Curcumin on SCC-25–PDLs interactions
were investigated in non-nuclear and nuclear fractions [23]. In
the non-nuclear extracts, ITGA5 was slightly upregulated (up to
110% by densitometry normalized to beta-actin) in co-cultured
PDLs similarly to SCC-25 cells, whereas, in 2 mM Curcumin-
treated co-culture, the ITGA5 protein levels were reduced (until
60% of the normal co-culture by densitometry normalized tobeta-actin) (Fig. 5A, top panel) in them. The interaction between
SCC-25 cells and PDLs is partly mediated by IL-1b [3], across
activation of interleukin-1 receptor-associated kinase-1 (IRAK).
The density relation of p-IRAK to IRAK in control cells was 0.64,
in co-cultured PDLs: 1.13 in curcumin-treated co-cultured PDLs:
1.21. Compared to control cells IRAK phosphorylation increased
in co-cultured PDL ﬁbroblasts (to 12779.4% by densitometry of
western blots normalized to beta-actin), and remained increased
in 2 mM Curcumin-treated co-cultured PDLs (98.9575.7% in
curcumin-treated co-culture compared to normal co-culture by
densitometry of western blots normalized to beta-actin)
(Fig. 5A). Cytoplasmatic levels of NFkBa have not changed in
control, co-cultured and Curcumin-treated co-cultured PDLs
(Fig. 5A, lowest panel). In the cell nuclear fraction NFkBa levels
increased in co-cultured PDLs related to cytoplasmatic levels
(1.4970.15 by densitometry), and this increase was lower in
Curcumin-treated co-cultured PDLs (1.2370.65 by densitometry)
(Fig. 5B).
Fig. 5 – Effects of Curcumin on the signal transduction of PDLs
in co-culture. After 4 days of co-culture (PDLs with SCC-25
cells) and in some experiments treatment of the co-culture
with 2 lM Curcumin: non-nuclear (A) and cell nuclear (B)
fractions of PDLs were analyzed by western blot using b-actin
as loading control. In non-nuclear protein fraction (A)
integrin av (ITGA5), IRAK, p-IRAK and NFjBa, in cell nuclear
fraction: NFjBa have been analyzed. Samples loaded on
polyacrylamide gels: MW: molecular weight marker, control
(1), co-cultured (2–4), co-cultured and 2 lM Curcumin-treated
co-cultured (5–7) PDL cells.
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In the current study we hypothesized that Curcumin targets the
dynamic mutual interaction of CAFs and tumor cells in head and
neck squamous cell carcinoma at such low concentration levels
that are achievable in vivo. We have clearly evidenced that
Curcumin treatment of co-culture between SCC-25 cells and
PDL oral ﬁbroblasts resulted in decrease of tumor cell migration
and invasivity, reversal of EMT in tumor cells, and decrease of the
EMT mediators’ gene expression and synthesis in ﬁbroblasts. The
modiﬁcation of the interaction between carcinoma associated
ﬁbroblasts and tumor cells is achieved at low Curcumin concen-
trations, which do not have growth suppression effects. This
study proves that Curcumin signal modulatory effects can be
studied independently from growth suppression effects.
The most important and clinically relevant result is the
reduction of tumor cell invasivity, based partially on the reduc-
tion of MMP-9 enzyme activity in tumor cells. The observation
that Curcumin might decrease MMP-9 gene expression has been
published before [26]. In that study of Mohan et al. this issue has
been related to inhibitory effect on activator protein-1 (AP-1).
Nevertheless, MMP-9 expression and activation might be alsorelated with the transcription factor NFkBa [26], which is one of
the main targets of Curcumin [7]. Chun et al. have reported that
Curcumin dissolved in acetone, applied from 1 mM to dorsal skin
of mice induced a dramatic reduction of – tetradecanoylphorbol-
13-acetate (TPA)-induced NFkBa – activation, and a slight
reduction of ERK1/2 activity [7]. These cell nuclear targets have
also been conﬁrmed in our study in co-cultured SCC-25 cells. The
interaction of SCC-25 tumor cells with ﬁbroblasts resulted in
increased ERK1/2 and NFkBa—levels, both of which decreased if
the co-culture was treated with Curcumin (Fig. 3B). Nevertheless,
the relative function of both ERK1/2 and NFkBa was not
inﬂuenced. Interestingly, Curcumin caused slightly decreased
NFkBa cell nuclear translocalization in co-cultured PDLs
(Fig. 5B).
As we have previously published, the ITGA5 is upregulated
both in SCC-25 cells and in PDL ﬁbroblasts in co-culture, and
might also contribute to regulation of MMP-9 [5]. Here, the
upregulation of ITGA5 is conﬁrmed at protein level both in
co-cultured SCC-25 cells and PDLs (Figs. 3 and 5). Curcumin
treatment of co-culture caused a decrease of the ITGA5 levels
both in ﬁbroblasts and tumor cells. Interestingly, this effect was
more enhanced in ﬁbroblasts. In fact, reduction effects of
Curcumin on gene expression of ITGA5 have been evidenced
previously in metastatic melanoma, which was accompanied by
increased expression of E-cadherin [27]. Increased expression of
E-cadherin has been also observed in Curcumin-treated
co-culture of SCC-25 cells (Fig. 2F), which is a sign of reversal
of EMT, and was accompanied with decreased expression of
vimentin (Fig. 2E).
Previous studies of our laboratory [2] and of others [28]
conﬁrmed an important participation of BDNF-TrkB system in
regulation of EMT. BDNF gene expression, as a mediator of EMT,
is upregulated in carcinoma-associated ﬁbroblasts (CAFs), which
are functionally comparable with co-cultured PDLs [2]. TrkB, the
receptor of BDNF is expressed in SCC-25 cells, and its phos-
phorylated form is increased in co-cultured SCC-25 cells. Curcu-
min treatment of co-culture decreases both the gene expression
of the EMT-mediator BDNF and the phospho-TrkB levels in SCC-
25 tumor cells, providing a plausible mechanistic background for
the reversal of EMT. Similarly to BDNF, also SDF gene expression
has been down regulated in PDLs of curcumin-treated co-culture.
Kupferman et al. suggested that TrkB is functioning through AKT
signaling [28]. AKT (another kinase of transcription, also known
as protein kinase B) is a protein kinase involved in signal
transduction from oncogenes and growth factors [6]. The data
on Curcumin’s effect on the AKT pathway is varying; while
Curcumin has been shown to act independently of AKT in HNSCC
as well as melanoma, whereas Curcumin suppresses the AKT
pathway in other tumors such as malignant gliomas and pan-
creatic cancer [6]. Conﬁrming this knowledge, Curcumin has also
not effected AKT in co-cultured SCC-25 cells (Fig. 3A).
The interaction of CAFs with tumor cells in supporting tumor
cell-EMT and invasivity is a complex one, where the involvement
of inﬂammatory cytokines produced by the tumor cells has been
evidenced [3]. These cytokines, exempliﬁed by IL-1b, might have
receptors on ﬁbroblasts and can regulate the expression of EMT-
mediators as SDF-1 and BDNF in them [3]. This regulation in case
of IL-1b, is mediated by IRAK. IRAK phosphorylation is increased
in co-culture in ﬁbroblasts and Curcumin-treatment of co-culture
has not affected it.
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co-culture in tumor cells were the decrease of p-TrkB, NFkBa and
ERK-levels, and in ﬁbroblasts: reduction of ITGA5 expression and
of NFkBa cell nuclear translocalization. These (and presumably
other) signal modulatory changes caused decreased release of
EMT-mediators in CAFs and reversal of EMT in tumor cells.
Reversal of EMT was associated with decreased invasion. These
data conﬁrm the palliative potential of Curcumin in clinical
application and underline the need of improved formulation for
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